Form 4: TransDigm Group Director Acquires Shares in Lieu of Fees

Sentiment:

SEC Form 4 Filing


Director Jane M. Cronin acquired 27 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee on March 26, 2025.

Summary

  • On March 26, 2025, Jane M. Cronin, a director of TransDigm Group INC, acquired 27 shares of common stock.
  • The acquisition was made in lieu of a semi-annual director fee, based on the fair market value of the stock.
  • The price per share was $1,346.5.
  • Following the transaction, Ms. Cronin directly owns 640.62 shares of TransDigm Group INC.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director taking stock in lieu of fees can be seen as a positive sign, indicating confidence in the company's future.

Positives

  • The director's decision to take shares in lieu of cash compensation demonstrates confidence in the company's future prospects.

Industry Context

Directors receiving stock in lieu of fees is a common practice, aligning their interests with shareholders and conserving company cash.

Related Party Transactions

  • The receipt of stock by the director in lieu of fees constitutes a related party transaction.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders.
  • It could be viewed positively by shareholders as it aligns the director's interests with theirs.

Key Dates

DateDescription
03/26/2025Date of transaction: Director acquired shares in lieu of fee.

Keywords

TransDigm Group INC, Director, Share Acquisition, Form 4, SEC, Director Fee, TDG, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.